Reducing postpartum depressive symptoms among black and Latina mothers: a randomized controlled trial
- PMID: 22488220
- PMCID: PMC3336015
- DOI: 10.1097/AOG.0b013e318250ba48
Reducing postpartum depressive symptoms among black and Latina mothers: a randomized controlled trial
Abstract
Objective: To estimate the effectiveness of a behavioral educational intervention to reduce postpartum depressive symptoms among minority mothers.
Methods: We recruited 540 self-identified black and Latina mothers during their postpartum hospital stay and randomized them to receive a behavioral educational intervention or enhanced usual care. Those in the intervention arm received a two-step behavioral educational intervention that prepares and educates mothers about modifiable factors associated with symptoms of postpartum depression (physical symptoms, low social support, low self-efficacy, and infant factors), bolsters social support, enhances management skills, and increases participants' access to resources. Enhanced usual care participants received a list of community resources and received a 2-week control call. Participants were surveyed before randomization and, 3 weeks, 3 months, and 6 months later to assess depressive symptoms. The primary outcome, depression, was assessed using the Edinburgh Postnatal Depression Scale (score of 10 or greater).
Results: Positive depression screens were less common among intervention compared with enhanced usual care posthospitalization: 3 weeks (8.8% compared with 15.3%, P=.03), 3 months (8.4% compared with 13.24%, P=.09), and 6 months (8.9% compared with 13.7%, P=.11). An intention-to-treat repeated-measures analysis for up to 6 months of follow-up demonstrated that mothers in the intervention group were less likely to screen positive for depression compared with enhanced usual care (odds ratio 0.67, 95% confidence interval [CI] 0.47-0.97; number needed to treat 16, 95% CI 9-112).
Conclusion: An action-oriented behavioral educational intervention reduced positive depression screens among black and Latina postpartum mothers.
Clinical trial registration: Clinicaltrials.gov, www.clinicaltrials.gov, NCT01312883.
Level of evidence: I.
Conflict of interest statement
Financial Disclosure: Pfizer supplies medication for an NIH-funded study on the treatment of postpartum depression which is led by Dr. Zlotnick. The other authors did not report any potential conflicts of interest.
References
-
- Martin JA, Hamilton BE, Sutton PD, Ventura SJ, Menacker F, Kirmeyer S. Births: final data for 2004. Natl Vital Stat Rep. 2006 Sep 29;55(1):1–101. - PubMed
-
- Zayas LH, Cunningham M, McKee MD, Jankowski KR. Depression and Negative Life Events Among Pregnant African-American and Hispanic Women. Women's Health Issues. 2002;12(1):16–21. - PubMed
-
- McKee MD, Cunningham M, Jankowski KR, Zayas L. Health-related functional status in pregnancy: relationship to depression and social support in a multi-ethnic population. Obstet Gynecol. 2001 Jun;97(6):988–993. - PubMed
Publication types
MeSH terms
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials